The venous blood samples were sent by overnight courier to the immune analysis laboratory where lymphocytes were separated on Lymphoprep (Flow Laboratories, Irvine, Scotland) and stored at −180°C.
The immunology assays were performed at the cytotoxic T lymphocyte laboratory (CTL) at the Joint clinical research center (JCRC), Kampala, Uganda.
Blood was obtained from each subject by venipuncture using heparinized Vacutainers and sent immediately to the laboratory for the lymphocyte cultures.
Laboratory testing, including lymphocyte count for rituximab and neutrophil count for tocilizumab, are warranted as treatment with each of these agents is associated with rapid depletion of peripheral B-cells [ 51] and neutropenia [ 44– 469]69], respectively (category A).
We did not evaluate the potential impact on morbidity and length of hospital stay of ADA, IFN-γ and Xpert compared to empiric treatment based on laboratory analysis alone (lymphocyte predominance), however, this would have require a randomized design and up to ~25% of TB effusions are known to be neutrophil pre-dominant [ 23].
Data from exams conducted in the network of accredited public laboratories, particularly TCD4+/TCD8 lymphocyte counting and HIV viral load (SISCEL - National Database for Laboratory Tests); iii.
Indeed, these sequences are identical to those observed in earlier mitochondrial work in our laboratory on blood lymphocytes, even in the number and location of sequence changes.
Laboratory features evaluated included lymphocyte count, C-reactive protein (CRP), nasopharyngeal and lower respiratory tract pandemic influenza (H1N1) 2009 PCR results.
HIV-related laboratory variables include CD4 lymphocyte count and HIV-1 viral load.
This measure of inflammation is based on standard laboratory measurements of total lymphocyte count and albumin, which are routinely measured in the clinical setting.
